I have read some ludicrous claims here (this is the land of the $10 billion deal after all), but the claim that BIT have not presented clinical trial results takes the cake. I would need more than a stiff drink to take this claim seriously.
Peer review is not some magic that suddenly finds all the errors in your manuscript and turns data into results, it is a couple of scientists looking over your paper and hopefully picking up more than the odd typo. While I would love to see BIT's trial published (not least so we get more details), peer review is not going to make the primary aim a success or turn post hoc analysis into a pre-registered objective.
@Southoz I have read your posts on other companies here on HC and you are no fool that just believes whatever the company says. Is there a reason other than being the devils advocate for your posts here?
Can I also ask why you want me to change to original title of this thread? If you would prefer to answer this off-line my email is [email protected]
BIT Price at posting:
8.4¢ Sentiment: Sell Disclosure: Not Held
(20min delay)